Cronos Stock Surges On Q1 Earnings Beat, 'Strong' Demand For Flower Products: '2025 Is Shaping Up To Be A Transformative Year'

Zinger Key Points

Cronos Group Inc CRON reported first-quarter financial results ahead of the market open Thursday. Here’s a look at the key highlights from the cannabis company’s report.

Q1 Revenue: Cronos reported first-quarter revenue of $32.26 million, beating analyst estimates of $31.70 million, according to Benzinga Pro. The company reported first-quarter earnings of 2 cents per share, beating estimates for a loss of 1 cent per share.

Cronos said first-quarter revenue increased 28% year-over-year, primarily driven by higher cannabis flower sales in Israel and other countries, as well as higher cannabis extract sales in the Canadian market.

The company noted that its Spinach brand ended the quarter as the second most popular brand in Canada with 4.6% market share. The company’s Lord Jones Chocolate Fusions had 9.6% market share in Canada at quarter’s end, and Peace Naturals continued to be a top-performing brand in Israel. Cronos also said it’s seeing strong traction in Germany and the U.K.

“2025 is shaping up to be a transformative year for Cronos as we execute our strategic priorities to drive revenue growth, expand margins, and maintain disciplined cost management,” said Mike Gorenstein, chairman, president and CEO of Cronos.

“While strong demand for our flower products has recently outpaced supply, we are confident that our Cronos GrowCo expansion, on track for completion in the second quarter with initial sales in the second half of the year, will unlock significant capacity to meet this demand and fuel our next phase of growth.”

The company’s board authorized a share repurchase program of up to $50 million on May 7. Repurchases may be made from time to time through the termination date on May 13, 2026.

Cronos ended the quarter with $838 million in cash, cash equivalents and short-term investments.

CRON Price Action: Cronos Group shares were up 8.65% at $2.01 at the time of publication Thursday, according to Benzinga Pro.

Loading...
Loading...

Read Next:

Photo: VladyslaV Travel photo/Shutterstock.

CRON Logo
CRONCronos Group Inc
$1.997.83%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
23.42
Growth
86.18
Quality
-
Value
64.53
Price Trend
Short
Medium
Long
Got Questions? Ask
Which cannabis companies are next to report earnings?
How will international markets impact cannabis sales?
What potential does Cronos' expansion hold for investors?
Which cannabis brands may gain market share in 2025?
How could Germany and the U.K. shape the cannabis sector?
Who benefits from strong demand for cannabis products?
What risks does cannabis supply constraints pose for investors?
How might the share repurchase program affect CRON stock?
Which companies will compete with Cronos in flower sales?
What trends in cannabis extracts should investors watch?
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:

Cannabis is evolving—don’t get left behind!

Curious about what’s next for the industry and how to stay ahead in today’s competitive market?

Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.

Secure your spot now before prices go up—this is where the biggest deals and connections happen!

Get your tickets today!

Comments
Loading...